-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GNcNeZhg4c4OL32qaBiWdK9t/+qd3OmOLE25k2l8UiddWlnYaL3mrcNfe7a6WAmq QdLImg87DHUvQGC4r9hDYw== 0000000000-07-041123.txt : 20071231 0000000000-07-041123.hdr.sgml : 20071231 20070822134244 ACCESSION NUMBER: 0000000000-07-041123 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070822 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C0X(#`@;V)J(#P\+TQI;F5A-IB8&!@96!@[F8``BX'!E3`",0L#!P-R&*L4,S`X,/`+:"V[B=7 M`IC'Q,`@R`&A&2P@>GE/0VAF6[AN-@8&I6,0449)@``#`&KV!HL-"F5N9'-T MF4@-#@O5'EP92]84F5F/CYS=')E M86T-"GC:8F)B9&!B8&`'1'4W1A=&4\/"]'4S`@-30@,"!2/CX^/B]4 M>7!E+U!A9V4^/@UE;F1O8FH--3$@,"!O8FH\/"]3=6)T>7!E+U1R=654>7!E M+T9O;G1$97-CF+:='R MF9DS9\[.7GRAMV\O/EW?WI!+[]Y=W5S3R*7'$2-)HXN?O^+W? M@'_1Q63;F'LA]E#")'#8:13^"I28.=YI%.\,BN=S"L/("4[#^+TPKN.Z+M?4 M3;:_OM`!=N`YD<&^7#^NRXHX'Q-WW6@H5-`?JFW0/@->S+7 MR#QL.G1O?2HH-3W#_&`T(,@NC<0+/^B7Y%HWRO5<1OX@W9 M$^:%[OFF#='8[PE]A3$>4L"3K4P^R*6@S\HA=\*2.$H&*^VWB_VB6+`UAD&8 M?BO8AW'963L>=@#7[WCWCWCWX[BU@!N1P@2T$7S3,Q]CYM\,,SPP]?W2\2/_ MG(NS$S/.NA*BX^[YH;OMWFU.&X4I6XJJ$@5E:24R:DS9,YX\UM^@0N@T#G3) MC"XCQPUT#1DX^;X6934FF>,_RI7*2T&5HIEZTOR(O+(GD06[9!;-"Z7?&<)V M9#[AKL:;,`>]!J95+03=R&=92I63FM=*5D5:Z8\?9)ZVB7558TYU8IZ#:3:9 M6?E,_,DY+ZFLTOE\3-4BK>A%T$LJGY'CHD7Q6A1N7(,YG&W+$RCK^UH6HBY' MUY%7NL"YG@+9D%E7U%'5*6G"T56^4]N]]4$5-0O,G?Q*RPD"`LJGI9J/8CLJE#XY.P?6O7K/!* MV!1M/7*;X(6Z;.6YK,4+Z!7ESI/9R"^;$6Y%#US MXIHY"6"7VSFI?2#-,\H4Y0I:$4LIZ@D1&S18/6/WH)1:L$Z!-=:$Q378CEK* M]1P=EF@$/:2E+/6\/$*!A3WAL,S*Y*?G"M;A$-W.ZP+P#:TG/(RD"J-A/`&Q MSE_DV$#NL-FG6-)D4"YTZQ4Z!D9JKD3F]*9KNAX[?M)FBR.,TF6I M>P[&*V'\4>?9>`:,M\_<=HV[0=Q)=K8N"MWWIG.@>ZF,Z_^D#X)K&[P[='?W M90RY@6PMN'2U:F/L.'JL0\"`D5UJQ(,SQ!PMV!57VC4VX*%:-$E_QXRO\;;V MZL10+[7![%1P.`@[7F)=_HX](G8B7P>I.]A1TOE<)\J^X['.F26.&S?#9;A$ MFW!TU4/::*3]Y^C@X,::Q=H>M4IJRE'-H/1(GIMAY-CF]SNR*B2270D\,B@% M8M1D[2ITV/[XZ[=?[5`<-U'.3]O?B?7WR*7VP7$_]0WX;:U,8X%IOJ':1[`< ME)0^J+7NF"QU_%TK]1V_F]1F^QG3:BE2+"PSE5=P3VK/>$KM"6Y;VB8P;]P) M`N9X`69SF*H?VZ=YX#GA&:I>L3]SW'SC,S#]^W.W^72`'OCEN/&Z!O&KQ`I5 MB.5F/(@]L%3WP.(^>TX:_?OR/@YN'%L5#.+TK\D'.+A]GN/_Q,6V6QD/+YHU M.&Z:IBO8G%26T7N'?DF+3)HKPZ"&O!.[P>$6=!`1%T^WB7@)EX+#P+[T2;;0 MCBCF=#F;J354#F\>#/]#=UV&^VA?1_\38`!O/KQ+#0IE;F1S=')E86T-96YD M;V)J#34S(#`@;V)J/#PO4W1E;58@.#(O1F]N=$YA;64O5&EM97-.97=2;VUA M;E!3350O1F]N=%-T%LM-38X("TS,#<@,C`P,"`Q,#`W M72]!7!E+T9O;G1$97-C7!E+T5X=$=3=&%T92]302!F86QS92]332`P+C`R/CX- M96YD;V)J#3$@,"!O8FH\/"]&:7)S="`S,3,O3&5N9W1H(#7!E+T]B:E-T;3X^4`\F65R+8%N+T\*_Y]T=PL>%L@=4 MJ8=X,NMWGYF=66MREK&"%9J53&G)1,:4%4P(9I5A0K+"9DPH5F::"8ATP81A M90FEA5CAD<,6$.&-D%"5L+9@$DL2``F:-)9);%%9QJ2"U88%J2KA(XQ&+`F4 M!D>"9[`H0Z07L('K]#PP2L*^."5V*3`*W/X M(24DI4I8:QBD4N"X6L`:^$A5(C^M8)&?UK#(+Z:*, M1H%YCE@0A*)'H\D8,I9,3J8@$X.&@DO)O$5Y,V5ZS8/NQ=H MZ6YWR_>;WWS6^>MJS4_Y0;MJN\%A`8\)FOGD?6]7SC\E-^G6Z^Z/6WW#!0C+ M5X_!IB':E$]\=>TB_<6!D2@)1J/__HJ@Y>/P`89;3H+4)VCQ!6R1HRY1>)#4NI7/B+:VS6[%*(:<4@[$=HHOQ^R_"_Z>YWZ]XM+($/M> M@`$`P]X)7PT*96YD7!E+UA-3"],96YG=&@@-#,U.2]4>7!E+TUE=&%D871A M/CYS=')E86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H M:4AZDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z M;G,Z;65T82\B('@Z>&UP=&L](C,N,2TW,#$B/@H@("`\3Y396-U&AA;F=E($-O;6UI3X*("`@ M("`@("`@/'!D9G@Z4V]U#I3;W5R8V5-;V1I9FEE9#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^ M"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@&%P.D-R96%T M;W)4;V]L/@H@("`@("`@("`\>&%P.DUO9&EF>41A=&4^,C`P-RTP."TR,E0Q M,SHS.3HS."TP-#HP,#PO>&%P.DUO9&EF>41A=&4^"B`@("`@("`@(#QX87`Z M365T861A=&%$871E/C(P,#&%P34TZ26YS=&%N8V5)1#YU=6ED.F4V8F(Q9&9D+31D-&,M-&(W M."TY,#AF+3DT9&9F8S0T,3,W83PO>&%P34TZ26YS=&%N8V5)1#X*("`@("`@ M("`@/'AA<$U-.E9E&%P34TZ5F5R&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R M9R]D8R]E;&5M96YT"UD969A=6QT(CY!<')I;"`Y+"`R,#`Q/"]R9&8Z;&D^"B`@ M("`@("`@("`@(#PO2A396-U&AA M;F=E($-O;6UIF4@-#@^/@T* -----END PRIVACY-ENHANCED MESSAGE-----